Many people still believe that taking a daily aspirin helps prevent having a stroke or heart attack, despite updated medical ...

Can-Fite BioPharma (CANF) announced a significant clinical development: the disappearance of episodes of decompensated liver cirrhosis ...

Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused ...

Compared with rivaroxaban, abelacimab is associated with fewer bleeding events in patients with AF and moderate to high risk for stroke.

More than 60,000 people in the U.S. bleed to death every year from traumatic events like car crashes or gunshot wounds, or ...

If you are taking daily aspirin and do not have a history of heart disease, talk to your doctor. The latest research suggests ...

The prognosis of patients with gastrointestinal stromal tumors is significantly impacted by gastrointestinal bleeding.

a 67% reduction in major bleeding, and an 89% reduction in gastrointestinal bleeding. The overall clinical benefit of abelacimab prompted the Independent Data Monitoring Committee to discontinue the ...

Millions of Americans take aspirin daily despite new health warnings.

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

The following is a summary of “Oakland score to identify low-risk patients with lower gastrointestinal bleeding performs well among emergency department patients,” published in the February 2025 issue ...

3 Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore Objective While it is recommended that patients presenting with acute upper gastrointestinal bleeding (AUGIB) should ...